Notice of the Annual General Meeting of Shareholders 2022

The shareholders of Eevia Health Abp, company registration number 2825194-4 in Finland, are hereby called for the Annual General Meeting (AGM) to be held on June 21st 2022.

The AGM will be held at 12:00 Finnish time at the main office of Eevia Health Abp in Koulukatu 14, Seinäjoki, Finland. The venue will be open from 11:30.

A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING

  1. Opening of the meeting
  2. Calling the meeting to order
  3. Election of persons to scrutinize the minutes and to supervise the counting of votes
  4. Recording legality of the meeting
  5. Recording the attendance at the meeting and adoption of the list of votes
  6. Presentation of the financial statements and auditor's report for the year 2021
  7. Adoption of financial statements for 2021
  8. Loss shown on the balance sheet and resolution on the payment of dividends

The Board of Directors proposes that the net loss of EUR - 2 635 577.02 is transferred to retained earnings/loss account and that no dividend be paid.

  1. Discharge from liability of the Board and Chief Executive Officer
  2. Resolution on the remuneration of the members of the Board of Directors

The Board of Directors of the company suggests the following remuneration to the Board:

Chairman:            20,000 € for the period until AGM in year 2023

Members: 10,000 € for the period until AGM in year 2023

  1. Resolution on the number of members of the Board of Directors

The Shareholders' Nomination Board has proposed that five (5) members be elected to the Board of Directors which is within the limits of the Company's current Articles of Association.

  1. Election of members of the Board of Directors

The Shareholders' Nomination Board has proposed that current Board members, Martin Bjørklund, Per Benjaminsen, Magne Ruus Simensen, and Johanna Panula will be re-elected members of the Board of Directors of Eevia Health Abp.

The Shareholders' Nomination Board has proposed that Oskar Wigelius will be elected as a new member of the Board of Directors of Eevia Health Abp.

Mr. Wegelius currently works as Area Lead, polyolefins at Borealis Polymers Oy. He has deep knowledge of process management, with technical focus on troubleshooting, debottlenecking and optimizing process conditions. His educational background is directly relevant to Eevia Health Abp's production process, focusing on liquefaction of lignin and ethanolysis. Mr. Wegelius holds a MSc in Chemical Engineering from Aalto University of Helsinki, where he was awarded Best Master's Thesis in his year.

Their term of office will continue until the next Annual General Meeting as stipulated in the Articles of Association.

  1. Resolution on the remuneration of the auditor

The Board of Directors proposes that the auditor's fees be paid according to the auditor's reasonable invoice approved by the company.

  1. Election of the auditor
  2. Closing of the meeting

B. DOCUMENTS OF THE GENERAL MEETING

The financial statements of Eevia Health Abp and the auditor's report as well as this notice including the proposals made to the General Meeting are available on Eevia Health Abp's website here: https://investor.eeviahealth.com/corporate-governance/general-meetings/2022/. The documents mentioned above are also available at the meeting. Minutes of the General Meeting are available on the above-mentioned website from 5 July 2022 at the latest.

C. INSTRUCTIONS FOR THE PARTICIPANTS

1. Shareholders registered in the shareholders' register

Each shareholder who is registered on the 9 June, 2022 at 16:00, EEST (Finnish time) at the latest in the shareholders' register of the company held by Euroclear Finland Ltd., has the right to participate in the General Meeting. A shareholder, whose shares are registered on his/her/its personal Finnish book-entry account, is registered in the shareholders' register of the company.

A shareholder, who wants to participate in the General Meeting, shall register for the meeting no later than 16 June 2022 at 10.00, EEST (Finnish time) by which time the registration shall be received. Shareholders who have a Finnish book-entry account may register by the following means:

  1. Through email: [email protected];
  2. by regular mail: to Eevia Health Abp, General Meeting, Koulukatu 14, 60100 Seinäjoki, Finland.
     

Requested information shall be given in connection with the registration such as name, personal identification number, address, email address and the name of a possible assistant or proxy representative, and the personal identification number of a proxy representative. The personal data given to Eevia Health Abp is used only in connection with the General Meeting and the processing of related necessary registrations and for shareholder communication. Shareholder, his/her/its representative or proxy representative shall, when necessary, be able to prove his/her/its identity and/or right of representation.

2. Holder of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the General Meeting by virtue of shares based on which he/she/it on the record date of the meeting, on 9 June 2022, 16:00 EEST (Finnish time) the latest, would be entitled to be registered in the shareholders' register of the company held by Euroclear Finland Ltd. The right to participate in the General Meeting requires, in addition, that the shareholder has been registered into the temporary shareholders' register of the company held by Euroclear Finland Ltd. at the latest on 16 June 2022 by 10:00, EEST (Finnish time). As regards nominee-registered shares this constitutes due registration for the General Meeting.

A holder of nominee-registered shares is advised without delay to request necessary instructions regarding the registration in the temporary shareholder's register of the company, the issuing of proxy documents and registration for the General Meeting from his/her/its custodian bank. The account management organization of the custodian bank must register a holder of nominee-registered shares, who wants to participate in the General Meeting, into the temporary shareholders' register of the company at the latest on the date and time mentioned above.

3. Shares registered at Euroclear Sweden AB

Shareholder whose shares are registered in the securities system of Euroclear Sweden AB and who wants to participate in the General Meeting and use his/her/its voting right, shall be registered at the shareholder's register held by Euroclear Sweden AB on 9 June 2022 17:00 CEST (Swedish time) at the latest.

In order to be entitled to request for temporary registration in the shareholder's register of Eevia Health Abp. held by Euroclear Finland Ltd., a shareholder of nominee-registered shares shall request that his/her/its shares are temporarily registered under his/her/its own name in the shareholder's register held by Euroclear Sweden AB and to ensure that the custodian bank will send the above-mentioned request for temporary registration to Euroclear Sweden AB. The registration shall be made on 9 June 2022, 17:00 CEST (Swedish time) at the latest, and therefore a shareholder shall give the request to his/her/its custodian bank in good time prior to the above date.

Shareholder, whose shares are registered in the securities system of Euroclear Sweden AB and who intends to participate in the General Meeting and use his/her/its voting right, shall request for a temporary registration of his/her shares to the shareholder's register of Eevia Health Abp held by Euroclear Finland Oy. The request to Eevia Health Abp shall be made in writing at the latest on 13 June 2022, 10:00 Swedish time. The temporary registration through Eevia Health Abp. constitutes a due registration to the General Meeting.

4. Proxy representative and powers of attorney

A shareholder may participate in the General Meeting and exercise his/her/its rights at the meeting by way of proxy representation.

 A proxy representative shall produce a dated proxy document or otherwise provide reliable evidence of the right to represent the shareholder. The authorization applies to one meeting unless otherwise stated. When a shareholder participates in the General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the General Meeting.

If you do not have access to a person who is able and willing to meet with your proxy, such proxy can also be given to Gabriella Beni, Chief Financial Officer. Please inform us by filling her name in the proxy form available on the Company's website here: https://investor.eeviahealth.com/corporate-governance/general-meetings/2022/ and send it to [email protected]

Proxy documents should be delivered via email to [email protected] by 11:00 am EEST (Finnish time) on June 21st, 2022 at the latest, or have your proxy representative bring them to the AGM. 

5. Other instructions and information

Pursuant to Chapter 5 Section 25 of the Finnish Companies Act, a shareholder who is present at the General Meeting has the right to request information with respect to the matters to be handled at the meeting.

On the date of the notice to the General Meeting, 2 June 2022, the total number of shares in Eevia Health Abp is 15,973,356. Each share carries one vote at General Meeting.

In Seinäjoki, 2 June 2022

EEVIA HEALTH ABP

Board of Directors

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                           Gabriella Beni, CFO, Eevia Health Plc

Email: [email protected]                      [email protected]

Telephone: +358 400 22 5967                                +358 407 48 8666

Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.

To learn more, please visit  www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth. 

Tuomas Jylhä joins Eevia Health Plc as Interim Chief Financial Officer

Eevia Health Plc ("Eevia" or "The Company") is welcoming Tuomas Jylhä as interim Chief Financial Officer. Gabriella Beni has decided to leave the Company for personal reasons to focus on private matters. Eevia wishes her the very best in her future endeavors. Tuomas Jylhä will take over the position on July 26th.


Eevia Health Plc being followed by Analyst Group

Analyst Group Initiates equity research Coverage of Eevia Health Plc, ("Eevia" or "The Company").


Eevia Health Plc receives a 5,8 MSEK/0,55 MEUR sales order for high concentrate anthocyanin organic bilberry extract

Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus.


Eevia Health Plc receives a 230 KSEK/21 KEUR starting sales order for a new Lingonberry product to a new customer

Eevia Health Plc, ("Eevia" or "The Company"), has received a 21 KEUR sales order from its Australian distributor Ingredients Plus for a new product made from Lingonberry, after a new customer has decided to launch a new product with the Lingonberry ingredient as a key component.


Eevia Health Plc has secured a credit line of SEK 8 million for working capital purposes to finance continued growth

Eevia Health Plc, ("Eevia" or "The Company"), has entered into an agreement whereby Exelity AB, Sweden will provide a credit line for Eevia of up to SEK 8 million, giving the Company increased working capital flexibility to finance its continued growth.


Communique from the Annual General Meeting in Eevia Health Plc

The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 21, 2022 in Seinäjoki, Finland, whereby the shareholders primarily resolved the following matters:


Eevia Health Plc receives a 2,3 MSEK/0,23 MEUR sales order for organic bilberry extract

Eevia Health Plc, ("Eevia" or "The Company"), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.


Notice of the Annual General Meeting of Shareholders 2022

The shareholders of Eevia Health Abp, company registration number 2825194-4 in Finland, are hereby called for the Annual General Meeting (AGM) to be held on June 21st 2022.


Eevia Health Plc publishes Financial Statements for 2021

Eevia Health Plc's (''Eevia'' or ''the Company'') Financial Statements for 2021 together with the Auditors' report have been published today.



Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted